Cargando…
“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that a...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040389/ https://www.ncbi.nlm.nih.gov/pubmed/17707545 http://dx.doi.org/10.1016/j.addr.2007.06.009 |
_version_ | 1782137088438697984 |
---|---|
author | Medina-Kauwe, L.K. |
author_facet | Medina-Kauwe, L.K. |
author_sort | Medina-Kauwe, L.K. |
collection | PubMed |
description | Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that are known to facilitate entry of pathogens and potential delivery agents. Recent characterization of the trafficking mechanisms of prion proteins and certain bacteria may present new paradigms for strategizing improvements in therapeutic spread and retention of therapy. This review will provide an overview of such endocytic pathways, and discuss current and future possibilities in using these routes as a means to improve therapeutic delivery. |
format | Text |
id | pubmed-2040389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-20403892007-10-23 “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() Medina-Kauwe, L.K. Adv Drug Deliv Rev Article Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that are known to facilitate entry of pathogens and potential delivery agents. Recent characterization of the trafficking mechanisms of prion proteins and certain bacteria may present new paradigms for strategizing improvements in therapeutic spread and retention of therapy. This review will provide an overview of such endocytic pathways, and discuss current and future possibilities in using these routes as a means to improve therapeutic delivery. Elsevier B.V. 2007-08-10 2007-07-05 /pmc/articles/PMC2040389/ /pubmed/17707545 http://dx.doi.org/10.1016/j.addr.2007.06.009 Text en Copyright © 2007 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Medina-Kauwe, L.K. “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() |
title | “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() |
title_full | “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() |
title_fullStr | “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() |
title_full_unstemmed | “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() |
title_short | “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() |
title_sort | “alternative” endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040389/ https://www.ncbi.nlm.nih.gov/pubmed/17707545 http://dx.doi.org/10.1016/j.addr.2007.06.009 |
work_keys_str_mv | AT medinakauwelk alternativeendocyticmechanismsexploitedbypathogensnewavenuesfortherapeuticdelivery |